End Sepsis – Rory’s Story
Editor's Note: Patient Worthy is honored to share this article with you, kindly provided to us by our friends at End Sepsis. To see the article in its original format,…
Continue Reading
End Sepsis – Rory’s Story
Treating Inflammation vs. Bacteria
According to recent reports, assistant pediatric professor at the Boston Children’s Hospital, Prof. Meenakshi Rao, noted that infections associated with Clostridioides difficile (C. Diff.) are difficult to eradicate. Nonetheless, once the infection is under…
Continue Reading
Treating Inflammation vs. Bacteria
Samsung Secures FDA Clearance for Galaxy Buds Hearing Assistance Technology
As reported on Fierce Biotech, Samsung Electronics has obtained clearance from the U.S. Food and Drug Administration (FDA) for software features that transform select Galaxy Buds earbuds into over-the-counter (OTC)…
Continue Reading
Samsung Secures FDA Clearance for Galaxy Buds Hearing Assistance Technology
Qiagen Secures FDA Clearance for First QIAstat-Dx Bloodstream Infection Test in the US
As reported on PharmaBiz, Qiagen has received US Food and Drug Administration (FDA) clearance for its QIAstat-Dx BCID GPF Plus AMR Panel, marking the company's entry into the US bloodstream…
Continue Reading
Qiagen Secures FDA Clearance for First QIAstat-Dx Bloodstream Infection Test in the US
Enfortumab Vedotin/Pembrolizumab Regimen Outperforms Neoadjuvant Chemotherapy in Resectable MIBC
As reported on The ASCO Post, perioperative treatment with enfortumab vedotin-ejfv plus pembrolizumab resulted in superior event-free survival, overall survival, and pathologic response rates compared with neoadjuvant cisplatin/gemcitabine in cisplatin-eligible…
Continue Reading
Enfortumab Vedotin/Pembrolizumab Regimen Outperforms Neoadjuvant Chemotherapy in Resectable MIBC
Tuberculosis Drug Discovery Gets Smarter with AI at Texas A&M AgriLife
According to a press release from Texas A &M, researchers are using artificial intelligence to narrow drug choices and make shared data easier to use. Tuberculosis drug discovery speeds up with new…
Continue Reading
Tuberculosis Drug Discovery Gets Smarter with AI at Texas A&M AgriLife
SpudCell: A Synthetic Cell that Grows and Reproduces
A team from Minnesota University has created a synthetic cell that includes lifeless chemicals and created a synthetic cell that will grow, reproduce, and even compete for food along with…
Continue Reading
SpudCell: A Synthetic Cell that Grows and Reproduces
Jon’s Caregiver Story
Editor's Note: This post was written and submitted to us by Jon Scheinman, and originally shared on LinkedIn. To see the article in its original format, please click here. I…
Continue Reading
Jon’s Caregiver Story
FDA Clears Kenvue’s OTC Tylenol-Naproxen Combination for Long-Lasting Pain Relief
As reported on Pharmaceutical Technology, Kenvue has received US Food and Drug Administration (FDA) approval for an over-the-counter (OTC) pain medication that combines acetaminophen and naproxen sodium in a single…
Continue Reading
FDA Clears Kenvue’s OTC Tylenol-Naproxen Combination for Long-Lasting Pain Relief
FDA Clears TorEx Lung Perfusion System, Expanding Options for Donor Lung Assessment
As reported on TechTimes, the U.S. Food and Drug Administration (FDA) has granted Premarket Approval to the TorEx® Lung Perfusion System, a new ex vivo lung perfusion (EVLP) platform developed…
Continue Reading
FDA Clears TorEx Lung Perfusion System, Expanding Options for Donor Lung Assessment
FDA Issues Final Guidance for Psychedelic Drug Trials, Clarifying Expectations for Developers
As reported on Clinical Trials Arena, the US Food and Drug Administration (FDA) has released its final guidance on the clinical development of psychedelic therapies, providing drug developers with a…
Continue Reading
FDA Issues Final Guidance for Psychedelic Drug Trials, Clarifying Expectations for Developers
Alebund Initiates Global Phase IIb Trial of AP306 for Hyperphosphatemia in Hemodialysis Patients
As reported on PharmaBiz, Alebund Pharmaceuticals has announced the first patient has been enrolled and treated in a global Phase IIb clinical trial evaluating AP306, an investigational therapy for hyperphosphatemia…
Continue Reading
Alebund Initiates Global Phase IIb Trial of AP306 for Hyperphosphatemia in Hemodialysis Patients
Two of Intellia Therapeutics’ Clinical Trials That Had Been on Hold Have Now Been Released by the FDA
Two of Intellia Therapeutics’ clinical trials that had been on hold since October 2025 have now been released by the FDA. The Agency initially issued the holds due to reports…
Continue Reading
Two of Intellia Therapeutics’ Clinical Trials That Had Been on Hold Have Now Been Released by the FDA
FDA Authorization Positions Johnson & Johnson to Enter Competitive Surgical Robotics Market
As reported on Fierce BioTech, Johnson & Johnson has received U.S. Food and Drug Administration (FDA) clearance for its Ottava Robotic Surgical System, marking a significant step in the company’s…
Continue Reading
FDA Authorization Positions Johnson & Johnson to Enter Competitive Surgical Robotics Market
Xeltis Launches aXess™ Hemodialysis Device in Europe Following First Commercial Implant
Medical device innovator Xeltis has officially kicked off the European commercial rollout of its novel vascular access implant, aXess™. The milestone was marked by the first routine commercial procedure, performed…
Continue Reading
Xeltis Launches aXess™ Hemodialysis Device in Europe Following First Commercial Implant
Teen Caregiver Finds New Purpose: Lilly’s Story
Editor's Note: This article was shared with us by our friends at the AAMDS International Foundation. To see the article in its original format, please click here. “I would like…
Continue Reading
Teen Caregiver Finds New Purpose: Lilly’s Story
Advances in Stroke Recovery
If you or a loved one has ever survived a stroke, you know that the hardest part of the journey often begins after you leave the hospital. Emergency room doctors…
Continue Reading
Advances in Stroke Recovery
Leadership Is More Than a Title
Editor's Note: This article was originally written and submitted to us by Regina Portnoy. When people think about leadership in clinical research, they often think about timelines, enrollment goals, budgets,…
Continue Reading
Leadership Is More Than a Title
Repairing the Wiring: How a New Stem Cell Therapy Aims to Defeat Chronic Spinal Cord Injury
As reported on Inside Precision Medicine, for years, a chronic spinal cord injury (SCI) has felt like a permanent biological roadblock. When the spinal cord is damaged, the immediate aftermath—known…
Continue Reading
Repairing the Wiring: How a New Stem Cell Therapy Aims to Defeat Chronic Spinal Cord Injury
“Two Rare Diagnoses, One Common Lesson: Start with Genetic Testing”
Every day, parents just like me sit in doctors’ offices searching for answers. They know something isn’t quite right. Maybe their child isn’t meeting milestones. Maybe their development has stalled,…
Continue Reading
“Two Rare Diagnoses, One Common Lesson: Start with Genetic Testing”
Heal Canada’s Summer 2026 Issue of E3 Advocacy Magazine
Our friends at Heal Canada have launched the newest edition of their magazine, E3 Advocacy! Their digital publication focuses on the importance of patient advocacy, patient stories, and bridging knowledge…
Continue Reading
Heal Canada’s Summer 2026 Issue of E3 Advocacy Magazine
FDA Grants Breakthrough Device Designation to Aurenar’s V-Link System for Preventing Cerebral Vasospasm After Brain Hemorrhage
As reported on MobiHealth News, the U.S. Food and Drug Administration (FDA) has awarded Breakthrough Device designation to Aurenar’s V-Link System, a noninvasive neuromodulation technology designed to help reduce cerebral…
Continue Reading
FDA Grants Breakthrough Device Designation to Aurenar’s V-Link System for Preventing Cerebral Vasospasm After Brain Hemorrhage
FDA Clears Orca Bio’s Tregzi for Adults Undergoing Allogeneic Stem Cell Transplantation for Blood Cancers
As reported on PharmaBiz, the US Food and Drug Administration (FDA) has approved Orca Bio’s Tregzi, a precision-engineered cell therapy designed for use in matched-donor allogeneic hematopoietic stem cell transplantation…
Continue Reading
FDA Clears Orca Bio’s Tregzi for Adults Undergoing Allogeneic Stem Cell Transplantation for Blood Cancers
Authentic Data is Becoming an Asset Class
Our friends and contributors at the TREND Community have provided us with another enlightening article, this time about high-quality human-generated data becoming a scarce and valuable asset as AI companies…
Continue Reading
Authentic Data is Becoming an Asset Class
Filling a Critical Gap: How TAF Removes Financial Barriers to Treatment
Editor's Note: Patient Worthy is proud and honored to share this article, provided by our friends at The Assistance Fund. Every year, thousands of families receive a rare disease diagnosis.…
Continue Reading
Filling a Critical Gap: How TAF Removes Financial Barriers to Treatment
